RA CAPITAL MANAGEMENT, L.P.

CIK 1346824 · EDGAR ↗
sum of disclosed values for 2026-03-31; 0 positions have no disclosed value and are left out of the sum, counted here rather than dropped
$9.4B
every reported holding for this filer and quarter, including ones with no disclosed value
86
positions with no comparable holding in the prior quarter (kind new), 2026-03-31
24
positions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record
10
Quarter-end snapshot, filed up to 45 days later — not current holdings. What a 13F covers ↓
FILING WINDOW OPEN
Q3 2026 filings are due by 2026-11-16 — figures for that quarter will change; missing filers are not zeros.

Changes · Quarter ended 2026-03-31. Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.

by shares · How classified ↗
Period
Position changes into quarter 2026-03-31
position matched across quarters by exact reported CUSIP over a registry gap — never a name matchNEW / ADD / TRIM / EXIT by share count · NO CHANGE = same shares; the value moved with price, so never an ADD or a TRIM · EXIT = absent this quarter (disposed, delisted, confidential, or reported by an affiliate) — the filing does not say which · NO PRIOR = no comparable prior quarter on record (a first filing, or a quarter filed inside an affiliate's report), so not called a new stake · n/c = not classifiable: value undisclosed on one side of the pair, or neither shares nor value can classify it · †v: the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGEderived by Public Filings from the published data; “no value” means the source did not disclose a usable value — never zeroreported unit changed across the pair (SH↔PRN); the share delta is withheld rather than fabricatedPrev valueCurr valuePrev sharesCurr shares
share class as filed: COMMON STOCK · position key pos:11660 · issuer key iss:1893ADD+$172M+750,000$495M$667M10,724,59911,474,599
share class as filed: COMMON STOCK · position key pos:13206 · issuer key iss:1335ADD+$70.5M+654,088$189M$260M1,880,0572,534,145
share class as filed: COMMON STOCK · position key pos:17547 · issuer key iss:577ADD+$153M+1,000,000$66.4M$219M1,611,7332,611,733
share class as filed: COMMON STOCK · position key sid:sec:prov:d00159df48fd34cc806ae902a076ba0a · issuer key cusip6:603170ADD−$57.4M+369,000$266M$208M7,323,7507,692,750
share class as filed: COMMON STOCK · position key sid:sec:prov:04667cad8d94d5f8ff4744e87dea829b · issuer key cusip6:85220GNEW+$208M+8,021,117$0$208M—8,021,117
share class as filed: COMMON STOCK · position key pos:14281 · issuer key iss:2313ADD−$114M+8,772,496$309M$196M18,203,00926,975,505
share class as filed: COMMON STOCK · position key pos:12161 · issuer key iss:587ADD−$258K+474,089$157M$157M1,976,1322,450,221
share class as filed: COMMON STOCK · position key sid:sec:prov:b23dd6a0ecec2737a5c87e9c74cf430d · issuer key cusip6:055477ADD+$27.3M+300,000$117M$144M6,955,9937,255,993
share class as filed: COMMON STOCK · position key pos:13828 · issuer key iss:2487NEW+$107M+5,707,262$0$107M—5,707,262
share class as filed: COMMON STOCK · position key pos:14114 · issuer key iss:1624NEW+$84.9M+3,902,596$0$84.9M—3,902,596
share class as filed: COMMON STOCK · position key sid:sec:prov:adbff6ad799c41f5a1fe4cddc6ffc42b · issuer key cusip6:30054YADD+$21.1M+35,868$59.2M$80.3M3,458,7703,494,638
share class as filed: COMMON STOCK · position key sid:sec:prov:1cc50bf992826e0d3df83d0835990c79 · issuer key cusip6:28658RADD−$300K+7,111$77.7M$77.4M11,293,82811,300,939
share class as filed: COMMON STOCK · position key pos:11739 · issuer key iss:1687ADD+$34.5M+3,528,555$32.8M$67.2M5,811,4239,339,978
share class as filed: COMMON STOCK · position key pos:16214 · issuer key iss:797NEW+$62.1M+2,399,310$0$62.1M—2,399,310
share class as filed: COMMON STOCK · position key sid:sec:prov:bc17a1945987420f684d9107b41fd336 · issuer key cusip6:98401FNEW+$59.1M+4,897,237$0$59.1M—4,897,237
share class as filed: COMMON STOCK · position key sid:sec:prov:5c1a00d8d9a697993fa04c560cf77d6b · issuer key cusip6:00509GADD+$18.0M+6,060,606$31.5M$49.5M14,932,06320,992,669
share class as filed: COMMON STOCK · position key sid:sec:prov:adc22e9a1524ab89aa68e69a21eb8d93 · issuer key cusip6:35104ETRIM+$4.6M−603,432$42.4M$47.0M5,653,2115,049,779
share class as filed: COMMON STOCK · position key sid:sec:prov:310355a827423f86fff2dece8e909dcb · issuer key cusip6:15673TNEW+$40.1M+17,754,430$0$40.1M—17,754,430
share class as filed: COMMON STOCK · position key sid:sec:prov:652160e4f88d5e68e96c8504db5fee2d · issuer key cusip6:25056LADD+$17.9M+1,511,592$13.7M$31.6M1,461,3812,972,973
share class as filed: COMMON STOCK · position key pos:11504 · issuer key iss:1236NEW+$29.4M+318,554$0$29.4M—318,554
share class as filed: COMMON STOCK · position key sid:sec:prov:09a6575686667c84597e4fe2b4841977 · issuer key cusip6:09077VNEW+$28.9M+1,650,648$0$28.9M—1,650,648
share class as filed: COMMON STOCK · position key pos:10215 · issuer key iss:62NEW+$26.9M+1,503,084$0$26.9M—1,503,084
share class as filed: COMMON STOCK · position key sid:sec:prov:cfab5f07b0b6fc7e17744bf457f942d7 · issuer key cusip6:00166BNEW+$26.1M+13,011,849$0$26.1M—13,011,849
share class as filed: COMMON STOCK · position key sid:sec:prov:d6ea93a81ffbe77fbd59d8ff01875a57 · issuer key cusip6:00461UNEW+$25.5M+6,804,072$0$25.5M—6,804,072
share class as filed: COMMON STOCK · position key pos:17702 · issuer key iss:1818NEW+$22.2M+746,841$0$22.2M—746,841
share class as filed: COMMON STOCK · position key sid:sec:prov:0492e747c8d37a4dab1ade9330576c2c · issuer key cusip6:75955JNEW+$20.5M+2,947,369$0$20.5M—2,947,369
share class as filed: COMMON STOCK · position key sid:sec:prov:fed138ced9737b90542a54b9484d2da0 · issuer key cusip6:10919WNEW+$19.3M+265,000$0$19.3M—265,000
share class as filed: COMMON STOCK · position key sid:sec:prov:c4149a9e14976bb08df8d6a0cb6dd6b6 · issuer key cusip6:869367NEW+$17.8M+715,307$0$17.8M—715,307
share class as filed: COMMON STOCK · position key sid:sec:prov:05537d56ca21ce3a27a9a933baf06b09 · issuer key cusip6:21217BTRIM−$8.0M−883,699$24.9M$16.9M2,179,7111,296,012
share class as filed: COMMON STOCK · position key pos:13569 · issuer key iss:975ADD+$3.7M+183,699$13.1M$16.8M141,964325,663
share class as filed: COMMON STOCK · position key sid:sec:prov:0d957017a1f6113a5600ce99517cee7f · issuer key cusip6:03675PNEW+$16.7M+3,000,000$0$16.7M—3,000,000
share class as filed: COMMON STOCK · position key sid:sec:prov:1b29f8f31311ff2217960a31a2f84a8d · issuer key cusip6:68277QNEW+$16.6M+3,998,333$0$16.6M—3,998,333
share class as filed: COMMON STOCK · position key sid:sec:prov:15b122a1959cdc720dffb69686bc9994 · issuer key cusip6:433313ADD+$10.3M+284,500$3.7M$14.1M80,113364,613
share class as filed: COMMON STOCK · position key pos:10670 · issuer key iss:1641ADD+$5.9M+151,843$7.5M$13.5M58,044209,887
share class as filed: COMMON STOCK · position key pos:15030 · issuer key iss:1951ADD+$8.0M+385,000$4.7M$12.8M144,400529,400
share class as filed: COMMON STOCK · position key pos:16387 · issuer key iss:2129NEW+$12.7M+1,250,000$0$12.7M—1,250,000
share class as filed: COMMON STOCK · position key pos:10611 · issuer key iss:190NEW+$11.6M+864,102$0$11.6M—864,102
share class as filed: COMMON STOCK · position key sid:sec:prov:da6009df94d75bf6125e284a1e4e13f1 · issuer key cusip6:48576UNEW+$10.7M+1,917,354$0$10.7M—1,917,354
share class as filed: COMMON STOCK · position key sid:sec:prov:055a2567de67e3d96ef1117e9fce8ec2 · issuer key cusip6:007002ADD+$69.4K+234,375$8.0M$8.1M948,2491,182,624
share class as filed: COMMON STOCK · position key sid:sec:prov:990effbc09610fc927e1edc54d252d9d · issuer key cusip6:221015NEW+$6.6M+450,000$0$6.6M—450,000
share class as filed: COMMON STOCK · position key sid:sec:prov:ab691dd1726079c9ad67b4851addd50d · issuer key cusip6:29446KNEW+$6.2M+3,096,336$0$6.2M—3,096,336
share class as filed: COMMON STOCK · position key sid:sec:prov:2cf06ac89e78fe7c69baaccedd98a9c7 · issuer key cusip6:556099NEW+$5.4M+1,864,176$0$5.4M—1,864,176
share class as filed: COMMON STOCK · position key sid:sec:prov:25db868bd92949401541405f5298734d · issuer key cusip6:56565PNEW+$5.0M+248,294$0$5.0M—248,294
pos:15409EXIT‡e−$14.1M−335,000$14.1M$0335,000—
pos:17166EXIT‡e−$2.5M−96,628$2.5M$096,628—
pos:18275EXIT‡e−$2.1M−43,976$2.1M$043,976—
sid:sec:prov:45fc32dac56f2bd3e501273f0a0a1e4dEXIT‡e−$82.6M−1,267,156$82.6M$01,267,156—
sid:sec:prov:5b7075010c7b576fa3867b69c9375e20EXIT‡e−$1.9M−793,749$1.9M$0793,749—
sid:sec:prov:71e6d7a9978be392e4db6948ea1b496aEXIT‡e−$2.0M−109,959$2.0M$0109,959—
sid:sec:prov:831c753eb8a6ce9972092ec4165601d4EXIT‡e−$69.2M−432,484$69.2M$0432,484—
sid:sec:prov:b436d0646c9759c2ba692c8fcd7924abEXIT‡e−$743M−3,365,523$743M$03,365,523—
sid:sec:prov:de0907d604dc0fc94b1a3f8dd009ab9fEXIT‡e−$42.3M−17,119,096$42.3M$017,119,096—
sid:sec:prov:fc7c842ed91a7e3b374f2a94cbad8d9aEXIT‡e−$623M−8,641,031$623M$08,641,031—

Ticker: no position here maps to a reviewed ticker. Flags: no row carries a flag.

1–20 of the 53 changes on this page

Mark-to-market only (no share change) · 42

Positions whose share count is identical in both quarters; the value changed with price, not with a decision.

Positions held with no share change into quarter 2026-03-31
position matched across quarters by exact reported CUSIP over a registry gap — never a name matchNEW / ADD / TRIM / EXIT by share count · NO CHANGE = same shares; the value moved with price, so never an ADD or a TRIM · EXIT = absent this quarter (disposed, delisted, confidential, or reported by an affiliate) — the filing does not say which · NO PRIOR = no comparable prior quarter on record (a first filing, or a quarter filed inside an affiliate's report), so not called a new stake · n/c = not classifiable: value undisclosed on one side of the pair, or neither shares nor value can classify it · †v: the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGEderived by Public Filings from the published data; “no value” means the source did not disclose a usable value — never zeroreported unit changed across the pair (SH↔PRN); the share delta is withheld rather than fabricatedPrev valueCurr valuePrev sharesCurr shares
share class as filed: SPONSORED ADR · position key pos:15965 · issuer key iss:175NO CHANGE+$159M0$2.2B$2.4B10,281,49610,281,496
share class as filed: COMMON STOCK · position key pos:16702 · issuer key iss:1556NO CHANGE−$134M0$714M$580M6,666,8376,666,837
share class as filed: COMMON STOCK · position key sid:sec:prov:47170149b82e95e4444c881acffa67fc · issuer key cusip6:90240BNO CHANGE+$147M0$321M$467M12,198,62512,198,625
share class as filed: COMMON STOCK · position key pos:10212 · issuer key iss:1665NO CHANGE−$10.4M0$407M$397M9,905,0459,905,045
share class as filed: COMMON STOCK · position key pos:11808 · issuer key iss:635NO CHANGE+$69.7M0$259M$328M10,428,43710,428,437
share class as filed: COMMON STOCK · position key pos:16384 · issuer key iss:2294NO CHANGE−$29.3M0$335M$306M9,550,1919,550,191
share class as filed: COMMON STOCK · position key sid:sec:prov:c07b19289bd1953ef889bf232426771d · issuer key cusip6:81734DNO CHANGE−$26.9M0$195M$168M6,995,8586,995,858
share class as filed: COMMON STOCK · position key sid:sec:prov:7f79da9ff584753bfd1b9acc24c00236 · issuer key cusip6:47103JNO CHANGE+$1.1M0$154M$156M11,189,69311,189,693
share class as filed: COMMON STOCK · position key pos:15075 · issuer key iss:265NO CHANGE+$27.2M0$123M$151M15,827,18615,827,186
share class as filed: COMMON STOCK · position key pos:11142 · issuer key iss:1475NO CHANGE+$10.3M0$110M$120M373,787373,787
share class as filed: COMMON STOCK · position key sid:sec:prov:592cbdfa12c811cc697874a89333d4bb · issuer key cusip6:G3855LNO CHANGE+$10.4M0$97.5M$108M7,676,6977,676,697
share class as filed: COMMON STOCK · position key pos:13793 · issuer key iss:1763NO CHANGE−$24.3M0$130M$105M23,555,64823,555,648
share class as filed: COMMON STOCK · position key sid:sec:prov:60242973181bde6041719c13381cdbb1 · issuer key cusip6:929033NO CHANGE+$25.7M0$70.7M$96.4M5,404,9985,404,998
share class as filed: COMMON STOCK · position key sid:sec:prov:b6aaf2a1d9a7b3e3e2f1185e3325ec7d · issuer key cusip6:374163NO CHANGE+$10.8M0$84.2M$95.0M63,771,36663,771,366
share class as filed: COMMON STOCK · position key pos:10399 · issuer key iss:1659NO CHANGE−$39.3M0$127M$87.2M10,860,97710,860,977
share class as filed: COMMON STOCK · position key pos:13625 · issuer key iss:45NO CHANGE+$28.7M0$53.1M$81.8M1,621,6201,621,620
share class as filed: COMMON STOCK · position key sid:sec:prov:b2c5772e4485594db19ea1629268b11e · issuer key cusip6:04317ANO CHANGE+$21.2M0$42.3M$63.5M9,853,3029,853,302
share class as filed: COMMON STOCK · position key sid:sec:prov:be515631054470e2500985b7cc1d1245 · issuer key cusip6:50180MNO CHANGE+$5.3M0$49.2M$54.5M2,208,6042,208,604
share class as filed: COMMON STOCK · position key sid:sec:prov:3b4a08cf659449a1ac1d2ee41e501b50 · issuer key cusip6:008064NO CHANGE−$5.1M0$56.6M$51.6M3,671,0833,671,083
share class as filed: COMMON STOCK · position key sid:sec:prov:b66dc0816f9158ee3c706ae6f74ba1a4 · issuer key cusip6:359616NO CHANGE−$22.0M0$68.5M$46.4M6,053,9606,053,960
share class as filed: COMMON STOCK · position key sid:sec:prov:f5ab5fc62f8ffc42012ac685dc8651c0 · issuer key cusip6:14070BNO CHANGE+$2.3M0$43.5M$45.8M1,507,8441,507,844
share class as filed: COMMON STOCK · position key pos:13935 · issuer key iss:1355NO CHANGE−$26.2M0$65.0M$38.8M2,600,0002,600,000
share class as filed: COMMON STOCK · position key sid:sec:prov:37d3b7d0376e44b079f1262ff7392888 · issuer key cusip6:52635NNO CHANGE−$28.6M0$66.9M$38.2M4,178,8234,178,823
share class as filed: COMMON STOCK · position key sid:sec:prov:8416c67ffd3651f6a5f8d9788c0f2e31 · issuer key cusip6:61023LNO CHANGE−$7.0M0$43.6M$36.6M667,207667,207
share class as filed: COMMON STOCK · position key pos:14877 · issuer key iss:1434NO CHANGE−$95.1M0$131M$35.5M20,064,54520,064,545
share class as filed: COMMON STOCK · position key sid:sec:prov:bd4b862f6cf27f7bbb6f4d26443faaca · issuer key cusip6:52886XNO CHANGE−$21.0M0$49.7M$28.7M5,000,0005,000,000
share class as filed: COMMON STOCK · position key pos:17554 · issuer key iss:2344NO CHANGE−$6.4M0$34.7M$28.3M1,020,4101,020,410
share class as filed: COMMON STOCK · position key sid:sec:prov:cb2ee571f458a0a64c1c152656def847 · issuer key cusip6:76200LNO CHANGE+$6.3M0$21.7M$28.0M9,180,0009,180,000
share class as filed: COMMON STOCK · position key sid:sec:prov:05937aba4ce92b128af1dbba8d10131b · issuer key cusip6:690469NO CHANGE+$6.3M0$17.5M$23.8M10,714,00010,714,000
share class as filed: COMMON STOCK · position key sid:sec:prov:d87c40180b837190c93dcee0de07232d · issuer key cusip6:65487UNO CHANGE+$2.8M0$20.0M$22.8M10,805,12910,805,129
share class as filed: COMMON STOCK · position key pos:12631 · issuer key iss:843NO CHANGE−$14.5M0$36.7M$22.1M428,266428,266
share class as filed: COMMON STOCK · position key sid:sec:prov:d5b8ae591253ff1bf9b2d55cf805085a · issuer key cusip6:12529RNO CHANGE+$5.8M0$15.3M$21.0M8,000,0008,000,000
share class as filed: COMMON STOCK · position key pos:12386 · issuer key iss:2347NO CHANGE−$5.2M0$24.9M$19.7M1,850,0001,850,000
share class as filed: COMMON STOCK · position key sid:sec:prov:03d750f8ea50214fdbd147c22363d0f6 · issuer key cusip6:78397TNO CHANGE+$396K0$16.5M$16.9M4,401,5004,401,500
share class as filed: COMMON STOCK · position key sid:sec:prov:fefbed769ea5db09695bd4a0f3004463 · issuer key cusip6:696389NO CHANGE−$4.3M0$16.7M$12.5M7,124,1167,124,116
share class as filed: COMMON STOCK · position key sid:sec:prov:d12e469a81d64fc16ec26d9812e44d82 · issuer key cusip6:004890NO CHANGE−$8.5M0$20.1M$11.6M8,340,5088,340,508
share class as filed: COMMON STOCK · position key sid:sec:prov:37b91915f07af95197894a79df85a91e · issuer key cusip6:05338FNO CHANGE−$2.1M0$12.0M$9.9M662,968662,968
share class as filed: COMMON STOCK · position key pos:15905 · issuer key iss:2186NO CHANGE−$1.5M0$9.8M$8.2M750,000750,000
share class as filed: W EXP 99/99/999 · position key pos:13843 · issuer key iss:2294NO CHANGE−$987K0$7.7M$6.7M333,333333,333
share class as filed: COMMON STOCK · position key sid:sec:prov:1266daf28de201038d46cc25c3965279 · issuer key cusip6:753018NO CHANGE−$5.2M0$11.5M$6.2M8,500,0008,500,000
share class as filed: COMMON STOCK · position key sid:sec:prov:b8c786653b026e22c790c6ce2c014925 · issuer key cusip6:95075ANO CHANGE+$1.3M0$4.2M$5.6M6,681,3076,681,307
share class as filed: COMMON STOCK · position key sid:sec:prov:72475b3732ae8a64b486fe41b469bb0b · issuer key cusip6:696077NO CHANGE+$143K0$1.1M$1.2M70,00070,000

Ticker: no position here maps to a reviewed ticker. Flags: no row carries a flag.

Holdings without a security ID are counted, not compared. Method ↗

Reported positions — 2026-03-31

84 issuers · 86 rows
View
This build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.
Every row below carries ticker not yet mapped — stated once here rather than repeated on every row.
Positions RA CAPITAL MANAGEMENT, L.P. reported for the quarter ended 2026-03-31, as that filer reported them
a position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filingShare of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets.value undisclosed on the filing: retained and counted, excluded from sums, never shown as $0SharesWt
ASCENDIS PHARMA A/S - ADR · SPONSORED ADR CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$2.4B10,281,49624.9%
VAXCYTE INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$667M11,474,5997.1%
RHYTHM PHARMACEUTICALS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$580M6,666,8376.1%
TYRA BIOSCIENCES INC · COMMON STOCK CUSIP 90240B106
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$467M12,198,6255.0%
SIONNA THERAPEUTICS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$397M9,905,0454.2%
EDGEWISE THERAPEUTICS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$328M10,428,4373.5%
NEWAMSTERDAM PHARMA CO NV
2 positions · 2 reported rows
Rows RA CAPITAL MANAGEMENT, L.P. reported for NEWAMSTERDAM PHARMA CO NV, as it reported them
NEWAMSTERDAM PHARMA CO NV · COMMON STOCK CUSIP — $306M9,550,191
NEWAMSTERDAM PHARMA CO NV-27 · W EXP 99/99/999 CUSIP — $6.7M333,333
$312M9,883,5243.3%
NUVALENT INC-A · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$260M2,534,1452.8%
DIANTHUS THERAPEUTICS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$219M2,611,7332.3%
MINERALYS THERAPEUTICS INC · COMMON STOCK CUSIP 603170101
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$208M7,692,7502.2%
SPYGLASS PHARMA INC · COMMON STOCK CUSIP 85220G109
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$208M8,021,1172.2%
WAVE LIFE SCIENCES LTD · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$196M26,975,5052.1%
SEPTERNA INC · COMMON STOCK CUSIP 81734D104
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$168M6,995,8581.8%
DISC MEDICINE INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$157M2,450,2211.7%
JANUX THERAPEUTICS INC · COMMON STOCK CUSIP 47103J105
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$156M11,189,6931.6%
BIOCRYST PHARMACEUTICALS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$151M15,827,1861.6%
BICARA THERAPEUTICS INC · COMMON STOCK CUSIP 055477103
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$144M7,255,9931.5%
PRAXIS PRECISION MEDICINES I · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$120M373,7871.3%
GH RESEARCH PLC · COMMON STOCK CUSIP G3855L106
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$108M7,676,6971.1%
ZAI LAB LTD-ADR · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$107M5,707,2621.1%
TAYSHA GENE THERAPIES INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$105M23,555,6481.1%
VOR BIOPHARMA INC · COMMON STOCK CUSIP 929033207
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$96.4M5,404,9981.0%
GERON CORP · COMMON STOCK CUSIP 374163103
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$95.0M63,771,3661.0%
ARS PHARMACEUTICALS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$87.2M10,860,9770.9%
SAREPTA THERAPEUTICS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$84.9M3,902,5960.9%
SPYRE THERAPEUTICS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$81.8M1,621,6200.9%
EVOMMUNE INC · COMMON STOCK CUSIP 30054Y107
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$80.3M3,494,6380.9%
CLIMB BIO INC
1 position · 2 reported rows
Rows RA CAPITAL MANAGEMENT, L.P. reported for CLIMB BIO INC, as it reported them
CLIMB BIO INC · COMMON STOCK CUSIP 28658R106 $60.4M8,821,067
CLIMB BIO INC · COMMON STOCK CUSIP 28658R106 $17.0M2,479,872
$77.4M11,300,9390.8%
SOLID BIOSCIENCES INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$67.2M9,339,9780.7%
ARTIVA BIOTHERAPEUTICS INC · COMMON STOCK CUSIP 04317A107
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$63.5M9,853,3020.7%
DAMORA THERAPEUTICS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$62.1M2,399,3100.7%
XENCOR INC · COMMON STOCK CUSIP 98401F105
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$59.1M4,897,2370.6%
LB PHARMACEUTICALS INC · COMMON STOCK CUSIP 50180M108
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$54.5M2,208,6040.6%
JADE BIOSCIENCES INC · COMMON STOCK CUSIP 008064206
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$51.6M3,671,0830.5%
ACUMEN PHARMACEUTICALS INC · COMMON STOCK CUSIP 00509G209
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$49.5M20,992,6690.5%
4D MOLECULAR THERAPEUTICS IN · COMMON STOCK CUSIP 35104E100
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$47.0M5,049,7790.5%
FULCRUM THERAPEUTICS INC · COMMON STOCK CUSIP 359616109
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$46.4M6,053,9600.5%
CAPRICOR THERAPEUTICS INC · COMMON STOCK CUSIP 14070B309
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$45.8M1,507,8440.5%
CENTURY THERAPEUTICS INC · COMMON STOCK CUSIP 15673T100
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$40.1M17,754,4300.4%
OLEMA PHARMACEUTICALS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$38.8M2,600,0000.4%
LENZ THERAPEUTICS INC · COMMON STOCK CUSIP 52635N103
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$38.2M4,178,8230.4%
MONOPAR THERAPEUTICS INC · COMMON STOCK CUSIP 61023L207
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$36.6M667,2070.4%
PEPGEN INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$35.5M20,064,5450.4%
DESIGN THERAPEUTICS INC · COMMON STOCK CUSIP 25056L103
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$31.6M2,972,9730.3%
MIRUM PHARMACEUTICALS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$29.4M318,5540.3%
BIOAGE LABS INC · COMMON STOCK CUSIP 09077V100
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$28.9M1,650,6480.3%
LEXEO THERAPEUTICS INC · COMMON STOCK CUSIP 52886X107
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$28.7M5,000,0000.3%
ASSEMBLY BIOSCIENCES INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$28.3M1,020,4100.3%
REZOLUTE INC · COMMON STOCK CUSIP 76200L309
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$28.0M9,180,0000.3%
AKTIS ONCOLOGY INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$26.9M1,503,0840.3%
ALX ONCOLOGY HOLDINGS INC · COMMON STOCK CUSIP 00166B105
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$26.1M13,011,8490.3%
ACLARIS THERAPEUTICS INC · COMMON STOCK CUSIP 00461U105
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$25.5M6,804,0720.3%
OVID THERAPEUTICS INC · COMMON STOCK CUSIP 690469101
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$23.8M10,714,0000.3%
NKARTA INC · COMMON STOCK CUSIP 65487U108
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$22.8M10,805,1290.2%
TRAVERE THERAPEUTICS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$22.2M746,8410.2%
GRAIL INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$22.1M428,2660.2%
C4 THERAPEUTICS INC · COMMON STOCK CUSIP 12529R107
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$21.0M8,000,0000.2%
RELMADA THERAPEUTICS INC · COMMON STOCK CUSIP 75955J402
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$20.5M2,947,3690.2%
BENITEC BIOPHARMA INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$19.7M1,850,0000.2%
BRIGHT MINDS BIOSCIENCES INC · COMMON STOCK CUSIP 10919W405
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$19.3M265,0000.2%
SUTRO BIOPHARMA INC · COMMON STOCK CUSIP 869367201
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$17.8M715,3070.2%
CONTINEUM THERAPEUTICS INC-A · COMMON STOCK CUSIP 21217B100
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$16.9M1,296,0120.2%
SAB BIOTHERAPEUTICS INC · COMMON STOCK CUSIP 78397T202
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$16.9M4,401,5000.2%
INSPIRE MEDICAL SYSTEMS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$16.8M325,6630.2%
ANTERIS TECHNOLOGIES GLOBAL · COMMON STOCK CUSIP 03675P102
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$16.7M3,000,0000.2%
ONKURE THERAPEUTICS INC-A · COMMON STOCK CUSIP 68277Q105
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$16.6M3,998,3330.2%
HINGE HEALTH INC-A · COMMON STOCK CUSIP 433313103
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$14.1M364,6130.1%
GENEDX HOLDINGS CORP · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$13.5M209,8870.1%
WAYSTAR HOLDING CORP · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$12.8M529,4000.1%
HELIX ACQUISITION CORP-CL A · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$12.7M1,250,0000.1%
PALISADE BIO INC · COMMON STOCK CUSIP 696389402
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$12.5M7,124,1160.1%
ACRIVON THERAPEUTICS INC · COMMON STOCK CUSIP 004890109
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$11.6M8,340,5080.1%
ATRIUM THERAPEUTICS INC · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$11.6M864,1020.1%
KARYOPHARM THERAPEUTICS INC · COMMON STOCK CUSIP 48576U205
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$10.7M1,917,3540.1%
AVALO THERAPEUTICS INC · COMMON STOCK CUSIP 05338F306
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$9.9M662,9680.1%
PERCEPTIVE CAPITAL SOLUTIONS · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$8.2M750,0000.1%
ADICET BIO INC · COMMON STOCK CUSIP 007002207
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$8.1M1,182,6240.1%
CORVUS PHARMACEUTICALS INC · COMMON STOCK CUSIP 221015100
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$6.6M450,0000.1%
RANI THERAPEUTICS HOLDINGS-A · COMMON STOCK CUSIP 753018100
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$6.2M8,500,0000.1%
EQUILLIUM INC · COMMON STOCK CUSIP 29446K106
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$6.2M3,096,3360.1%
WEREWOLF THERAPEUTICS INC · COMMON STOCK CUSIP 95075A107
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$5.6M6,681,3070.1%
MACROGENICS INC · COMMON STOCK CUSIP 556099109
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$5.4M1,864,1760.1%
MAPLIGHT THERAPEUTICS INC · COMMON STOCK CUSIP 56565P103
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$5.0M248,2940.1%
PALATIN TECHNOLOGIES INC · COMMON STOCK CUSIP 696077601
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$1.2M70,0000.0%

1–20 of 84 issuers

Ticker: no reported row here maps to a reviewed ticker.

1–84 of 84 issuers · page 1 of 1
One line per issuer, largest first — open a line for its reported rows. Grouping ↗

Book shape

Tick = median of the 8,748 tracked filers with a 2026-03-31 book (the index median: the 8,662 with a complete book). Concentration uses reported 13F long value, not total assets; the index is withheld when any position lacks a value.
share of the period's disclosed value held in the top-N positions; denominator is reported 13F value, not total assets
82.3%above median 80.0%
integer Herfindahl–Hirschman index in basis points over disclosed position values
831 bpsabove median 446 bps
holdings with no disclosed value (undisclosed, or unreadable on the filing) — kept and counted, never shown as zero
86 / 86median book 97.5 positions

95 quarter-over-quarter rows

Filing history

Available filing periods
PeriodSource
2026-03-31EDGAR ↗
Complete source filings on SEC EDGAR

The filing on EDGAR is the record, including any filed after this build.

Open RA CAPITAL MANAGEMENT, L.P.'s 13F filings on SEC EDGAR ↗
A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗

13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.

Positions are quarter-end snapshots filed up to 45 days late — not current holdings: a position may have changed or closed since the quarter ended.

Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars; each record notes its original unit.

Affiliated managers may report the same position, so one position can appear under more than one filer.

Positions under confidential treatment may be omitted until a later amendment discloses them.

These are disclosures, not investment advice.